Cited by 113Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsBarrier Structure and Function Studies

Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice

Sullivan, P.M, Mace, B.E, Maeda, N, Schmechel, D.E·2004·Neuroscience

Abstract

We used three human apolipoprotein (apo) E targeted replacement mouse lines, each expressing one of the three common human apoE isoforms to study the pattern of apoE expression in the central nervous system (CNS). Immunocytochemistry on brain sections from all three lines of targeted replacement mice, wild type mice, African green monkeys, and humans show a predominantly glial pattern of apoE expression. The levels of human apoE protein in hippocampus and frontal cortex were similar between targeted replacement mice and non-demented human tissue. Within a given brain region, the levels of apoE were very similar amongst all three isoforms, which contrasts sharply with plasma, where apoE2 levels are 16-fold higher than apoE3 and E4 levels. Across brain regions, cerebellar apoE levels were significantly higher than cerebral apoE levels. In conclusion, we provide detailed analysis of a human apoE animal model system that recapitulates both the pattern and level of apoE expression in non-demented humans. The neurobiology of human apoE isoforms can now be studied in both the normal and post-injury state, since all apoE regulatory sequences are intact. Finally, the differences in apoE levels we observed may explain the regional vulnerability of neuronal degeneration in Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1016/j.neuroscience.2003.10.011

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APOE targeted replacement mice express human APOE in place of their mouse Apoe gene and do not develop overt AD pathology.

    “APOE targeted replacement mice, which express human APOE in place of their mouse Apoe gene and which do not develop overt AD pathology28,29”
  • Human ApoE protein is predominantly expressed in glia in hApoE-TR mice, recapitulating the pattern of ApoE expression in non-demented human brains.

    “Additionally, immunohistochemistry analyses revealed that human ApoE protein is predominantly expressed in the glia, which recapitulates the pattern of ApoE expression in the non-demented human brains (Sullivan et al., 2004).”
  • An initial study characterizing human apoE knock-in mice suggested that apoE levels in the mouse brains were not significantly different among the apoE2, apoE3, and apoE4 isoforms.

    “An initial study characterizing such mice suggested that apoE levels in the mouse brains were not significantly different among the apoE2, apoE3, and apoE4 isoforms (Sullivan et al., 2004).”

    From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Sullivan et al., 2004

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sullivan, P. M., Mace, B. E., Maeda, N., & Schmechel, D. E.
Affiliations
  • Duke University (US)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
Sullivan, P.M
Venue
Neuroscience
Publisher
Elsevier BV
Published
2004-01
Volume
124
Issue
4
Pages
725-733
ISSN
0306-4522 (ISSN-L)
OpenAlex
W1982180106
Cited by
113
References
11
Citations by year
2026: 5 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 8 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 7
FWCI
2.34
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Syracuse University
  • National Institute on Aging (P50AG005128, P50 AG05128-18)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
apolipoprotein E, APOE isoforms, targeted replacement mice, regional brain differences, glial expression, hippocampus, frontal cortex, cerebellum, Alzheimer's disease, neuronal vulnerability
MeSH terms
Aged, Alleles, Animals, Apolipoproteins E, Brain, Chlorocebus aethiops, Humans, Immunohistochemistry, Male, Mice, Transgenic, Neuroglia, Tissue Distribution, Blotting, Western, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review